PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Haematology, Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia.\', \'School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia.\', \'Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children\'s Hospital Medical Center, Cincinnati, Ohio.\', \'Section of Clinical Biochemistry, University of Verona, Verona, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1055/s-0041-1729856
?:doi
?:hasPublicationType
?:journal
  • Seminars in thrombosis and hemostasis
is ?:pmid of
?:pmid
?:pmid
  • 34130341
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.159
?:rankingScore_hIndex
  • 89
is ?:relation_isRelatedTo_publication of
?:title
  • Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all